mhurhangee/ep-ind-claims huggingface dataset:
A control device adapted to control a robot including a robot arm provided with a force detection section, the control device comprising: a control section adapted to operate the robot arm to move a screw gauge which is disposed on a tip side of the force detection section of the robot arm, used for an inspection of a screw hole (82, 83), and has a screw part (32, 33), to make the screw part (32, 33) have contact with the screw hole (82, 83), and then detect force applied to the screw gauge using the force detection section to perform force control in a direction perpendicular to a direction of an axis of the screw hole (82, 83) based on detection information of the force detection section, and operate the robot arm to move the screw gauge, wherein the control section is configured to stop the force control in the direction of the axis on the robot in at least a part of a zone when inserting the screw part (32, 33) into the screw hole (82, 83) in the subsequent step after making the screw part (32, 33) have contact with the screw hole (82, 83). a control section adapted to operate the robot arm to move a screw gauge which is disposed on a tip side of the force detection section of the robot arm, used for an inspection of a screw hole (82, 83), and has a screw part (32, 33), to make the screw part (32, 33) have contact with the screw hole (82, 83), and then detect force applied to the screw gauge using the force detection section to perform force control in a direction perpendicular to a direction of an axis of the screw hole (82, 83) based on detection information of the force detection section, and operate the robot arm to move the screw gauge, wherein operate the robot arm to move a screw gauge which is disposed on a tip side of the force detection section of the robot arm, used for an inspection of a screw hole (82, 83), and has a screw part (32, 33), to make the screw part (32, 33) have contact with the screw hole (82, 83), and then detect force applied to the screw gauge using the force detection section to perform force control in a direction perpendicular to a direction of an axis of the screw hole (82, 83) based on detection information of the force detection section, and operate the robot arm to move the screw gauge, wherein the control section is configured to stop the force control in the direction of the axis on the robot in at least a part of a zone when inserting the screw part (32, 33) into the screw hole (82, 83) in the subsequent step after making the screw part (32, 33) have contact with the screw hole (82, 83).
A method performed by a session management function, SMF, in a wireless communication system, the method comprising: transmitting, to a data network authentication authorization accounting, DN-AAA, server, a first message for authenticating a protocol data unit, PDU, session associated with a terminal during establishment of said PDU session; said method being characterized by: receiving, from the DN-AAA server, a second message as a response to the first message, the second message including a data network, DN, profile index; requesting a policy control function, PCF, so as to receive, from the PCF, a quality of service, QoS, profile associated with the DN profile index. receiving, from the DN-AAA server, a second message as a response to the first message, the second message including a data network, DN, profile index; requesting a policy control function, PCF, so as to receive, from the PCF, a quality of service, QoS, profile associated with the DN profile index.
A modified hyaluronic acid and/or a salt thereof comprising a glycerin skeleton-containing group shown by the following general formula, -O-CH 2 -CHOH-CH 2 -OR 1 ··· wherein, R 1 represents a linear or branched alkyl group, or a linear or branched alkenyl group.
An ink composition for continuous deflected ink jet printing, liquid at ambient temperature, comprising: a) a solvent comprising, preferably consisting of, one or more organic solvent compound(s), and optionally water, the said solvent representing at least 20% by weight, preferably 30% to 90% by weight, more preferably 60% to 80% by weight of the total weight of the ink composition of the total weight of the ink composition; b) at least one compound imparting conductivity to the ink composition, chosen from among ionic liquids, namely liquid salts comprising a cation and an anion, the said compound representing 0.2% by weight to 4% by weight of the total weight of the ink composition, preferably 0.5 to 3% by weight of the total weight of the ink composition; and the ink composition comprising less than 10% by weight, preferably less than 5% by weight, more preferably less than 1% by weight, and most preferably 0% by weight of water relative to the total weight of the ink composition; and said ionic liquids being chosen from among the ionic liquids that are liquid at a temperature of 100°C or lower. a) a solvent comprising, preferably consisting of, one or more organic solvent compound(s), and optionally water, the said solvent representing at least 20% by weight, preferably 30% to 90% by weight, more preferably 60% to 80% by weight of the total weight of the ink composition of the total weight of the ink composition; b) at least one compound imparting conductivity to the ink composition, chosen from among ionic liquids, namely liquid salts comprising a cation and an anion, the said compound representing 0.2% by weight to 4% by weight of the total weight of the ink composition, preferably 0.5 to 3% by weight of the total weight of the ink composition; and the ink composition comprising less than 10% by weight, preferably less than 5% by weight, more preferably less than 1% by weight, and most preferably 0% by weight of water relative to the total weight of the ink composition; and said ionic liquids being chosen from among the ionic liquids that are liquid at a temperature of 100°C or lower.
A monoclonal anti-CD95L antibody or a functional fragment thereof that specifically binds to an epitope comprising amino acids 13-19 of human CD95L, wherein the antibody comprises a heavy chain comprising an amino acid sequence including a CDRH1 as shown in SEQ ID NO: 1, or an amino acid sequence differing in 1 or 2 amino acids therefrom, a CDRH2 as shown in SEQ ID NO: 2, or an amino acid sequence differing in 1 or 2 amino acids therefrom, and a CDRH3 as shown in SEQ ID NO: 3, or an amino acid sequence differing in 1 or 2 amino acids therefrom, and a light chain comprising an amino acid sequence including a CDRL1 as shown in SEQ ID NO: 4, or an amino acid sequence differing in 1 or 2 amino acids therefrom, a CDRL2 as shown in SEQ ID NO: 5, or an amino acid sequence differing in 1 or 2 amino acids therefrom, and a CDRL3 as shown in SEQ ID NO: 6, or an amino acid sequence differing in 1 or 2 amino acids therefrom. a CDRH1 as shown in SEQ ID NO: 1, or an amino acid sequence differing in 1 or 2 amino acids therefrom, a CDRH2 as shown in SEQ ID NO: 2, or an amino acid sequence differing in 1 or 2 amino acids therefrom, and a CDRH3 as shown in SEQ ID NO: 3, or an amino acid sequence differing in 1 or 2 amino acids therefrom, and a CDRL1 as shown in SEQ ID NO: 4, or an amino acid sequence differing in 1 or 2 amino acids therefrom, a CDRL2 as shown in SEQ ID NO: 5, or an amino acid sequence differing in 1 or 2 amino acids therefrom, and a CDRL3 as shown in SEQ ID NO: 6, or an amino acid sequence differing in 1 or 2 amino acids therefrom.
A method for a User Equipment, the method comprising: sending, to an Access and Mobility management Function, a first Registration Request message as a registration procedure, the first Registration Request message including a first Subscription Concealed Identifier, SUCI, for identifying the UE, wherein the first SUCI is generated by concealing a Subscription Permanent Identifier, SUPI, for permanently identifying the UE; and starting a first timer T3510 and a second timer, in a case where the first Registration Request message has been sent; wherein the method further comprises: starting a third timer T3511 in a case where the first timer T3510 expires, and sending, to the AMF, a second Registration Request message, in a case where the registration procedure is restarted when the third timer T3511 expires, wherein the second Registration Request message includes the first SUCI that was sent in the first Registration Request message if the second timer is running, or the second Registration Request message includes a second SUCI that is generated by concealing the SUPI if the second timer is not running, the second SUCI being different from the first SUCI. sending, to an Access and Mobility management Function, a first Registration Request message as a registration procedure, the first Registration Request message including a first Subscription Concealed Identifier, SUCI, for identifying the UE, wherein the first SUCI is generated by concealing a Subscription Permanent Identifier, SUPI, for permanently identifying the UE; and starting a first timer T3510 and a second timer, in a case where the first Registration Request message has been sent; wherein the method further comprises: starting a third timer T3511 in a case where the first timer T3510 expires, and sending, to the AMF, a second Registration Request message, in a case where the registration procedure is restarted when the third timer T3511 expires, wherein starting a third timer T3511 in a case where the first timer T3510 expires, and sending, to the AMF, a second Registration Request message, in a case where the registration procedure is restarted when the third timer T3511 expires, wherein the second Registration Request message includes the first SUCI that was sent in the first Registration Request message if the second timer is running, or the second Registration Request message includes a second SUCI that is generated by concealing the SUPI if the second timer is not running, the second SUCI being different from the first SUCI.
A metal profile for the production of building frames, concealed frames or frames for inspection boxes and the like, which are installed flush with the plaster, wherein the metal profile has, on the base surface facing towards the masonry or timber-frame wall, grooves for the attachment of fastening brackets, characterized in that the metal profile has a U-shaped cross-section with two mutually parallel or converging flanges (4b, 4c) which form a seat for the insertion of a batten or of a profile, wherein the flange of the metal profile that is located further away from the region of the hinges for a wing forms a stop for a wing, wherein the stop has a groove for the insertion of a seal, and wherein the stop has a plaster edge projecting transversely to the thickness of the plaster layer that is to be applied, which plaster edge forms an angle of approximately 90° with the corresponding flange, wherein the other flange has a further plaster edge, wherein the two plaster edges each have an approximately 45° bevel to the plaster layer, wherein, in the region close to these plaster edges, towards the plaster layer that is to be applied, there is provided in each case at least one groove or one protruding rib for the attachment of a reinforcing mesh by the latter being clipped on, pushed in or glued on.
A compound: or a pharmaceutically acceptable salt thereof, for use in the treatment of a disorder mediated by complement Factor D in a human subject, wherein the disorder is selected from inflammatory effects of sepsis, systemic inflammatory response syndrome (SIRS), ischemia/ reperfusion injury (I/R injury), psoriasis, myasthenia gravis, system lupus erythematosus, paroxysmal nocturnal hemoglobinuria, hereditary angioedema, multiple sclerosis, trauma, burn injury, capillary leak syndrome, obesity, diabetes, Alzheimer's dementia, stroke, schizophrenia, epilepsy, age-related macular degeneration, glaucoma, diabetic retinopathy, asthma, allergy, acute respiratory distress syndrome (ARDS), atypical hemolytic uremic syndrome (aHUS), hemolytic uremic syndrome, cystic fibrosis, myocardial infarction, lupus nephritides, Crohn's disease, rheumatoid arthritis, atherosclerosis, transplant rejection, prevention of fetal loss, biomaterial reactions, C3 glomerulonephritis, abdominal aortic aneurysm, neuromyelitis optica, vasculitis, neurological disorders, Guillain Barre Syndrome, traumatic brain injury, Parkinson's disease, disorders of inappropriate or undesirable complement activation, hemodialysis complications, hyperacute allograft rejection, xenograft rejection, interleukin-2 induced toxicity during IL-2 therapy, inflammatory disorders, inflammation of autoimmune diseases, adult respiratory distress syndrome, thermal injury, myocarditis, post-ischemic reperfusion conditions, balloon angioplasty, post-pump syndrome in cardiopulmonary bypass or renal bypass, hemodialysis, renal ischemia, mesenteric artery reperfusion after aortic reconstruction, immune complex disorders and autoimmune diseases, SLE nephritis, proliferative nephritis, liver fibrosis, hemolytic anemia, tissue regeneration, neural regeneration, dyspnea, hemoptysis, chronic obstructive pulmonary disease (COPD), emphysema, pulmonary embolisms and infarcts, pneumonia, fibrogenic dust diseases, pulmonary fibrosis, organic dust diseases, chemical injury, smoke injury, thermal injury, bronchoconstriction, hypersensitivity pneumonitis, parasitic diseases, Goodpasture's Syndrome, pulmonary vasculitis, Pauci-immune vasculitis, immune complex-associated inflammation, uveitis, antiphospholipid syndrome, arthritis, autoimmune heart disease, inflammatory bowel disease, Barraquer-Simons Syndrome, hemodialysis, systemic lupus, lupus erythematosus, transplantation, diseases of the central nervous system and other neurodegenerative conditions, glomerulonephritis, blistering cutaneous diseases, ocular cicatrical pemphigoid, MPGN II, adult macular degeneration, diabetic retinopathy, retinitis pigmentosa, macular edema, Behcet's uveitis, multifocal choroiditis, Vogt-Koyanagi-Harada syndrome, intermediate uveitis, birdshot retino-chorioditis, sympathetic ophthalmia, ocular dicatricial pemphigoid, ocular pemphigus, nonarteritic ischemic optic neuropathy, postoperative inflammation, and retinal vein occlusion.
Headrest device comprising a headrest and a back support associated with a harness for maintaining said back support on the back of a user wearing said device, wherein the said headrest is mounted elastically tilting on the back support following movements in extension of the head of the wearer, characterised in that it further comprises means of elastic extension by which the headrest is mounted elastically sliding in longitudinal translation along the back support and is axially driven to a nominal resting position against movements of the head of the wearer tending to sink it into the back support.
An electrochemical cell comprising: a fuel electrode for oxidizing a metal fuel; an air electrode configured to absorb and reduce oxygen; at least one low temperature ionic liquid comprising positive ions and negative ions, wherein the at least one low temperature ionic liquid is a protic ionic liquid, an aprotic ionic liquid, or a combination thereof; and a positive-negative ion complex having positive ions coordinated with one or more negative ions, wherein the positive ions are formed by the dissociation of an oxygen reduction enhancing compound; wherein the oxygen reduction enhancing compound comprises at least one additive selected from a group consisting of triflic acid (HTf), benzonitrile: HTf, acetophenone: HTf, methanesulfonic acid, hydronium triflate, pyridazinium triflate, acetic acid, pyridinium triflate, 1,2-dimethylimidaozlium triflate, n,n-diethyl-n-methylammonium triflate, 2,2,2-trifluoroethanol, and 2-butyl-1,1,3,3-tetramethylguanidinium triflate. a fuel electrode for oxidizing a metal fuel; an air electrode configured to absorb and reduce oxygen; at least one low temperature ionic liquid comprising positive ions and negative ions, wherein the at least one low temperature ionic liquid is a protic ionic liquid, an aprotic ionic liquid, or a combination thereof; and a positive-negative ion complex having positive ions coordinated with one or more negative ions, wherein the positive ions are formed by the dissociation of an oxygen reduction enhancing compound; wherein the oxygen reduction enhancing compound comprises at least one additive selected from a group consisting of triflic acid (HTf), benzonitrile: HTf, acetophenone: HTf, methanesulfonic acid, hydronium triflate, pyridazinium triflate, acetic acid, pyridinium triflate, 1,2-dimethylimidaozlium triflate, n,n-diethyl-n-methylammonium triflate, 2,2,2-trifluoroethanol, and 2-butyl-1,1,3,3-tetramethylguanidinium triflate.
Method of controlling a braking function of a brake of an elevator by means of a brake control circuit comprising a first switch that controls the electricity supply of a winding of the brake, wherein the switch is switched in a controlled manner with short pulses by a control (37, 39) of the electricity supply of the winding of the brake, wherein after the electricity supply of the winding of the brake has been disconnected by opening a second controllable switch, the energy stored in the winding is discharged into an intermediate circuit of the brake control circuit via a release branch (6, 7) to collect the magnetization energy stored in the winding of the brake by means of a capacitor being connected between the rails that transfer output current and return current to the intermediate circuit, so that the energy stored can also then be re-used as magnetization energy of the winding of the brake.
A Machine Type Communication-Inter Working Function, MTC-IWF, comprising: a relay unit configured to receive an MTC device trigger message from a Service Capability Server, SCS, and deliver the MTC device trigger message over a control plane to a User Equipment, UE; characterized by: a generation unit configured to generate a Charging Data Record, CDR, including a field indicating an address of the MTC-IWF for the MTC device trigger message when the MTC-IWF receives a response from the UE that successfully received the delivery; and a transfer unit configured to transfer the CDR to a Charging Data Function, CDF, for charging the MTC device trigger message. a relay unit configured to receive an MTC device trigger message from a Service Capability Server, SCS, and deliver the MTC device trigger message over a control plane to a User Equipment, UE; characterized by: a generation unit configured to generate a Charging Data Record, CDR, including a field indicating an address of the MTC-IWF for the MTC device trigger message when the MTC-IWF receives a response from the UE that successfully received the delivery; and a transfer unit configured to transfer the CDR to a Charging Data Function, CDF, for charging the MTC device trigger message. a generation unit configured to generate a Charging Data Record, CDR, including a field indicating an address of the MTC-IWF for the MTC device trigger message when the MTC-IWF receives a response from the UE that successfully received the delivery; and a transfer unit configured to transfer the CDR to a Charging Data Function, CDF, for charging the MTC device trigger message.
An apparatus comprising an array (40; 90) of pixel sensors, each pixel sensor (41, 91) comprising a photodetector, a charge conversion circuit, and a gate transistor, said charge conversion circuit generating a voltage signal that is a function of a charge on said photodetector, and said gate transistor coupling said voltage signal to a bit line in response to a first signal; and a signal digitizing circuit comprising first and second amplifiers (55, 54) connected to said bit line, said first and second amplifiers generating first and second analog output signals, respectively, and first and second analog-to-digital converters (56, 57) that convert said first and second analog output signals to first and second output digital values, respectively, characterized by: said first and second output digital values having first and second levels of digitization noise, said first level of digitization noise being less than said second level of digitization noise; and a switch that connects one of said first and second output digital values from said analog-to-digital converters to an output line according to said voltage signal on said bit line, wherein when said voltage signal is less than a preset voltage (Vs), said first analog-to-digital converter is connected to said output line and otherwise, said second analog-to-digital converter is connected to said output line and wherein the preset voltage is set to maintain said digitization noise in said signal on said output line at a level that is always less than a predetermined fraction of the shot noise in said voltage signal.
Method for resistance welding, wherein welding processes are carried out, in the course of which, in each case in accordance with predefined welding parameters, welding electrodes (111, 112) are pressed against a welding spot of workpieces (121, 122) and are energized with a welding current, wherein, in the course of these welding processes, in each case at least one characteristic value that characterizes a quality of the welding is determined, wherein, after a number of welding processes which have been carried out, a statistical analysis of the determined characteristic values is carried out (203, 204, 205, 206) and wherein, in dependence on a result of this statistical analysis, it is determined whether an adaptation of the predefined welding parameters is carried out, characterized in that the statistical analysis is carried out in dependence on a median (Øt) and a dispersion (σ) of spattering times at which in each case welding spatter occurs during a respective welding process, and the statistical analysis is carried out in dependence on a difference between the median (Øt) of the spattering times and a product of the standard deviation (σ) of the spattering times and a predefinable constant. wherein, in dependence on a result of this statistical analysis, it is determined whether an adaptation of the predefined welding parameters is carried out, characterized in that the statistical analysis is carried out in dependence on a median (Øt) and a dispersion (σ) of spattering times at which in each case welding spatter occurs during a respective welding process, and the statistical analysis is carried out in dependence on a difference between the median (Øt) of the spattering times and a product of the standard deviation (σ) of the spattering times and a predefinable constant.
A control method for two or more air-conditioner water chilling units, comprising: receiving standby requests generated by the air-conditioner water chilling units based on a standby condition; determining whether or not two or more standby requests are received; generating standby sequence numbers of the air-conditioner water chilling units that send the standby requests according to the standby requests in case where two or more standby requests are received; and closing the air-conditioner water chilling units that send the standby requests according to a preset rule based on the standby sequence numbers. receiving standby requests generated by the air-conditioner water chilling units based on a standby condition; determining whether or not two or more standby requests are received; generating standby sequence numbers of the air-conditioner water chilling units that send the standby requests according to the standby requests in case where two or more standby requests are received; and closing the air-conditioner water chilling units that send the standby requests according to a preset rule based on the standby sequence numbers.